BioAdaptives, Inc.
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.01
FAIR PRICE
$0.02
MARGIN
$0.01
P/E Ratio
N/A
Div. Yield
N/A
ROE
78.5%
Exceptional
Market Cap
$109435
Small-cap
FPI RATING
Consistent growth trajectory and high-quality fundamentals, but weak profitability margins and volatile earnings pattern.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$0.02
Fair price × 0.80
DISTANCE
15.9%
Price to entry level
At the current price of $0.01, BDPT trades 15.9% below the conservative entry level of $0.02. The stock is currently priced below the 20% margin of safety threshold, indicating a potential value opportunity based on the model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
Loading chart data...
COMING SOON
Get notified when BDPT's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
James E. Keener
COUNTRY
US
HEADQUARTERS
Las Vegas
SECTOR
Consumer Defensive
EXCHANGE
OTC
METHODOLOGY
How we calculate BDPT's fair price
BioAdaptives, Inc.'s fair price of $0.02 is derived from a blended model that combines DCF analysis (50%), relative valuation against Consumer Defensive peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.01, BDPT trades 44.9% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting BDPT's risk profile.
RELATIVE · 30%
Comparing BDPT's valuation multiples against Consumer Defensive peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for BDPT, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate BDPT's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for BDPT.
Explore on BuliosFAQ
What is the fair price of BDPT?+
Based on our blended model combining DCF analysis (50%), relative valuation against Consumer Defensive peers (30%), and analyst consensus (20%), the fair price for BioAdaptives, Inc. is $0.02. At the current market price of $0.01, BDPT trades 44.9% below its calculated fair value.
Is BDPT overvalued or undervalued?+
BioAdaptives, Inc. is currently undervalued based on our valuation model. The stock trades at $0.01, which is 44.9% below the fair price of $0.02.
What is the margin of safety for BDPT?+
With a 20% margin of safety applied to the fair price of $0.02, the conservative entry level for BDPT is $0.02. At the current market price of $0.01, the stock trades 15.9% below this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is BDPT's fair price updated?+
We update fair price calculations for BDPT daily after market close. The current fair price of $0.02 incorporates the latest market data and sector multiples.
What factors affect BDPT's fair price calculation?+
BDPT's fair price of $0.02 is derived from DCF analysis (50% weight), relative valuation against Consumer Defensive peers (30% weight), and analyst consensus (20% weight)., ROE of 78.5%.
Is BDPT a good buy right now?+
At $0.01, BDPT trades 44.9% below our fair value estimate of $0.02. The stock is currently undervalued. ROE stands at 78.5% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does BDPT pay dividends?+
BDPT does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.